Insider Buying: EBOS Group Limited (ASX:EBO) Insider Purchases A$68,800.00 in Stock

EBOS Group Limited (ASX:EBO) insider Mark Bloom purchased 2,000 shares of the business’s stock in a transaction on Friday, May 30th. The shares were acquired at an average price of A$34.40 ($22.34) per share, with a total value of A$68,800.00 ($44,675.32).

EBOS Group Stock Performance

The company has a current ratio of 0.95, a quick ratio of 0.76 and a debt-to-equity ratio of 66.89. The stock has a market cap of $8.20 billion, a PE ratio of 27.51 and a beta of 0.26.

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.